Therapeutic challenges in childhood sickle cell disease - Part 1: Current and future treatment options

被引:24
作者
Amrolia, PJ
Almeida, A
Halsey, C
Roberts, IAG
Davies, SC
机构
[1] Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplantat, London WC1N 3JH, England
[2] Great Ormond St Hosp Sick Children, Dept Haematol, London WC1N 3JH, England
[3] Cent Middlesex Hosp, Dept Haematol, London NW10 7NS, England
[4] Imperial Coll Fac Med, Dept Haematol, London, England
关键词
sickle cell disease; transfusion; hydroxyurea; bone marrow transplantation;
D O I
10.1046/j.1365-2141.2003.04143.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:725 / 736
页数:12
相关论文
共 101 条
[61]   Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission [J].
Oakhill, A ;
Pamphilon, DH ;
Potter, MN ;
Steward, CG ;
Goodman, S ;
Green, A ;
Goulden, P ;
Goulden, NJ ;
Hale, G ;
Waldman, H ;
Cornish, JMM .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (03) :574-578
[62]   Indications for red cell transfusion in sickle cell disease [J].
Ohene-Frempong, K .
SEMINARS IN HEMATOLOGY, 2001, 38 (01) :5-13
[63]  
OHENEFREMPONG K, 1991, SEMIN HEMATOL, V28, P213
[64]   Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major [J].
Olivieri, NF ;
Brittenham, GM ;
McLaren, CE ;
Templeton, DM ;
Cameron, RG ;
McClelland, RA ;
Burt, AD ;
Fleming, KA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (07) :417-423
[65]   Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom [J].
Olujohungbe, A ;
Hambleton, I ;
Stephens, L ;
Serjeant, B ;
Serjeant, G .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) :661-665
[66]   Correction of sickle cell disease in transgenic mouse models by gene therapy [J].
Pawliuk, R ;
Westerman, KA ;
Fabry, ME ;
Payen, E ;
Tighe, R ;
Bouhassira, EE ;
Acharya, SA ;
Ellis, J ;
London, IM ;
Eaves, CJ ;
Humphries, RK ;
Beuzard, Y ;
Nagel, RL ;
Leboulch, P .
SCIENCE, 2001, 294 (5550) :2368-2371
[67]   RISK OF RECURRENT STROKE IN PATIENTS WITH SICKLE-CELL DISEASE TREATED WITH ERYTHROCYTE TRANSFUSIONS [J].
PEGELOW, CH ;
ADAMS, RJ ;
MCKIE, V ;
ABBOUD, M ;
BERMAN, B ;
MILLER, ST ;
OLIVIERI, N ;
VICHINSKY, E ;
WANG, W ;
BRAMBILLA, D .
JOURNAL OF PEDIATRICS, 1995, 126 (06) :896-899
[68]   A SHORT-TERM TRIAL OF BUTYRATE TO STIMULATE FETAL-GLOBIN GENE-EXPRESSION IN THE BETA-GLOBIN DISORDERS [J].
PERRINE, SP ;
GINDER, GD ;
FALLER, DV ;
DOVER, GH ;
IKUTA, T ;
WITKOWSKA, HE ;
CAI, SP ;
VICHINSKY, EP ;
OLIVIERI, NF .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (02) :81-86
[69]   Gene therapy for the hemoglobin disorders: Past, present, and future [J].
Persons, DA ;
Nienhuis, AW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5022-5024
[70]   Oral iron chelation therapy for thalassaemia: An uncertain scene [J].
Pippard, MJ ;
Weatherall, DJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (01) :2-5